 | • レポートコード：GIR-105X20033 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、徐放性注射剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。徐放性注射剤の種類別市場規模（ナルトレキソン、エクセナチド、エストラジオール、その他）、用途別市場規模（糖尿病、白血病、先端巨大症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・徐放性注射剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Eli Lilly、Sanofi、Roche、Novartis、Aurobindo、Avadel、Biomarin、Camurus、Critical Pharmaceuticals、Alkermes、Amylin、Ascendis Pharma、Taiwan Liposome Company ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ナルトレキソン、エクセナチド、エストラジオール、その他 ・用途別分析2016年-2026年：糖尿病、白血病、先端巨大症、その他 ・徐放性注射剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・徐放性注射剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・徐放性注射剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・徐放性注射剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・徐放性注射剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sustained Release Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Sustained Release Injectables size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Sustained Release Injectables market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Sustained Release Injectables market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Naltrexone
Exenatide
Estradiol
Other
Market segment by Application can be divided into
Diabetes
Leukemia
Acromegaly
Other
The key market players for global Sustained Release Injectables market are listed below:
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Ascendis Pharma
Taiwan Liposome Company
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Sustained Release Injectables Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sustained Release Injectables Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Naltrexone
1.2.3 Exenatide
1.2.4 Estradiol
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Sustained Release Injectables Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Other
1.4 Global Sustained Release Injectables Market Size & Forecast
1.4.1 Global Sustained Release Injectables Sales in Value (2016-2026))
1.4.2 Global Sustained Release Injectables Sales in Volume (2016-2026)
1.4.3 Global Sustained Release Injectables Price by Type (2016-2026) & (USD/Unit)
1.5 Global Sustained Release Injectables Production Capacity Analysis
1.5.1 Global Sustained Release Injectables Total Production Capacity (2016-2026)
1.5.2 Global Sustained Release Injectables Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sustained Release Injectables Market Drivers
1.6.2 Sustained Release Injectables Market Restraints
1.6.3 Sustained Release Injectables Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Sustained Release Injectables Product and Services
2.1.4 AstraZeneca Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Sustained Release Injectables Product and Services
2.2.4 Eli Lilly Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Sustained Release Injectables Product and Services
2.3.4 Sanofi Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Sustained Release Injectables Product and Services
2.4.4 Roche Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Sustained Release Injectables Product and Services
2.5.4 Novartis Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Aurobindo
2.6.1 Aurobindo Details
2.6.2 Aurobindo Major Business
2.6.3 Aurobindo Sustained Release Injectables Product and Services
2.6.4 Aurobindo Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Avadel
2.7.1 Avadel Details
2.7.2 Avadel Major Business
2.7.3 Avadel Sustained Release Injectables Product and Services
2.7.4 Avadel Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Biomarin
2.8.1 Biomarin Details
2.8.2 Biomarin Major Business
2.8.3 Biomarin Sustained Release Injectables Product and Services
2.8.4 Biomarin Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Camurus
2.9.1 Camurus Details
2.9.2 Camurus Major Business
2.9.3 Camurus Sustained Release Injectables Product and Services
2.9.4 Camurus Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Critical Pharmaceuticals
2.10.1 Critical Pharmaceuticals Details
2.10.2 Critical Pharmaceuticals Major Business
2.10.3 Critical Pharmaceuticals Sustained Release Injectables Product and Services
2.10.4 Critical Pharmaceuticals Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Alkermes
2.11.1 Alkermes Details
2.11.2 Alkermes Major Business
2.11.3 Alkermes Sustained Release Injectables Product and Services
2.11.4 Alkermes Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Amylin
2.12.1 Amylin Details
2.12.2 Amylin Major Business
2.12.3 Amylin Sustained Release Injectables Product and Services
2.12.4 Amylin Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Ascendis Pharma
2.13.1 Ascendis Pharma Details
2.13.2 Ascendis Pharma Major Business
2.13.3 Ascendis Pharma Sustained Release Injectables Product and Services
2.13.4 Ascendis Pharma Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Taiwan Liposome Company
2.14.1 Taiwan Liposome Company Details
2.14.2 Taiwan Liposome Company Major Business
2.14.3 Taiwan Liposome Company Sustained Release Injectables Product and Services
2.14.4 Taiwan Liposome Company Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Sustained Release Injectables Sales by Manufacturer
3.1 Global Sustained Release Injectables Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sustained Release Injectables Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sustained Release Injectables
3.4 Market Concentration Rate
3.4.1 Top 3 Sustained Release Injectables Manufacturer Market Share
3.4.2 Top 6 Sustained Release Injectables Manufacturer Market Share
3.5 Global Sustained Release Injectables Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sustained Release Injectables Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sustained Release Injectables Market Size by Region
4.1.1 Global Sustained Release Injectables Sales in Volume by Region (2016-2026)
4.1.2 Global Sustained Release Injectables Revenue by Region (2016-2026)
4.2 North America Sustained Release Injectables Revenue (2016-2026)
4.3 Europe Sustained Release Injectables Revenue (2016-2026)
4.4 Asia-Pacific Sustained Release Injectables Revenue (2016-2026)
4.5 South America Sustained Release Injectables Revenue (2016-2026)
4.6 Middle East and Africa Sustained Release Injectables Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sustained Release Injectables Sales in Volume by Type (2016-2026)
5.2 Global Sustained Release Injectables Revenue by Type (2016-2026)
5.3 Global Sustained Release Injectables Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sustained Release Injectables Sales in Volume by Application (2016-2026)
6.2 Global Sustained Release Injectables Revenue by Application (2016-2026)
6.3 Global Sustained Release Injectables Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sustained Release Injectables Sales by Type (2016-2026)
7.2 North America Sustained Release Injectables Sales by Application (2016-2026)
7.3 North America Sustained Release Injectables Market Size by Country
7.3.1 North America Sustained Release Injectables Sales in Volume by Country (2016-2026)
7.3.2 North America Sustained Release Injectables Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sustained Release Injectables Sales by Type (2016-2026)
8.2 Europe Sustained Release Injectables Sales by Application (2016-2026)
8.3 Europe Sustained Release Injectables Market Size by Country
8.3.1 Europe Sustained Release Injectables Sales in Volume by Country (2016-2026)
8.3.2 Europe Sustained Release Injectables Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sustained Release Injectables Sales by Type (2016-2026)
9.2 Asia-Pacific Sustained Release Injectables Sales by Application (2016-2026)
9.3 Asia-Pacific Sustained Release Injectables Market Size by Region
9.3.1 Asia-Pacific Sustained Release Injectables Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sustained Release Injectables Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sustained Release Injectables Sales by Type (2016-2026)
10.2 South America Sustained Release Injectables Sales by Application (2016-2026)
10.3 South America Sustained Release Injectables Market Size by Country
10.3.1 South America Sustained Release Injectables Sales in Volume by Country (2016-2026)
10.3.2 South America Sustained Release Injectables Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sustained Release Injectables Sales by Type (2016-2026)
11.2 Middle East & Africa Sustained Release Injectables Sales by Application (2016-2026)
11.3 Middle East & Africa Sustained Release Injectables Market Size by Country
11.3.1 Middle East & Africa Sustained Release Injectables Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sustained Release Injectables Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sustained Release Injectables Typical Distributors
12.3 Sustained Release Injectables Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Sustained Release Injectables Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sustained Release Injectables Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Sustained Release Injectables Product and Services
Table 6. AstraZeneca Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Sustained Release Injectables Product and Services
Table 10. Eli Lilly Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Sustained Release Injectables Product and Services
Table 14. Sanofi Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Sustained Release Injectables Product and Services
Table 18. Roche Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Sustained Release Injectables Product and Services
Table 22. Novartis Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 24. Aurobindo Major Business
Table 25. Aurobindo Sustained Release Injectables Product and Services
Table 26. Aurobindo Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Avadel Basic Information, Manufacturing Base and Competitors
Table 28. Avadel Major Business
Table 29. Avadel Sustained Release Injectables Product and Services
Table 30. Avadel Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biomarin Basic Information, Manufacturing Base and Competitors
Table 32. Biomarin Major Business
Table 33. Biomarin Sustained Release Injectables Product and Services
Table 34. Biomarin Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Camurus Basic Information, Manufacturing Base and Competitors
Table 36. Camurus Major Business
Table 37. Camurus Sustained Release Injectables Product and Services
Table 38. Camurus Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Critical Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Critical Pharmaceuticals Major Business
Table 41. Critical Pharmaceuticals Sustained Release Injectables Product and Services
Table 42. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Alkermes Basic Information, Manufacturing Base and Competitors
Table 44. Alkermes Major Business
Table 45. Alkermes Sustained Release Injectables Product and Services
Table 46. Alkermes Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Amylin Basic Information, Manufacturing Base and Competitors
Table 48. Amylin Major Business
Table 49. Amylin Sustained Release Injectables Product and Services
Table 50. Amylin Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Ascendis Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Ascendis Pharma Major Business
Table 53. Ascendis Pharma Sustained Release Injectables Product and Services
Table 54. Ascendis Pharma Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Taiwan Liposome Company Basic Information, Manufacturing Base and Competitors
Table 56. Taiwan Liposome Company Major Business
Table 57. Taiwan Liposome Company Sustained Release Injectables Product and Services
Table 58. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Sustained Release Injectables Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Sustained Release Injectables Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Sustained Release Injectables, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Sustained Release Injectables Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Sustained Release Injectables Production Site of Key Manufacturer
Table 64. Global Sustained Release Injectables Sales by Region (2016-2021e) & (K Units)
Table 65. Global Sustained Release Injectables Sales by Region (2021-2026) & (K Units)
Table 66. Global Sustained Release Injectables Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Sustained Release Injectables Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 69. Global Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 70. Global Sustained Release Injectables Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Sustained Release Injectables Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Sustained Release Injectables Price by Type (2016-2021e) & (USD/Unit)
Table 73. Global Sustained Release Injectables Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 75. Global Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 76. Global Sustained Release Injectables Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Sustained Release Injectables Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Sustained Release Injectables Price by Application (2016-2021e) & (USD/Unit)
Table 79. Global Sustained Release Injectables Price by Application (2021-2026) & (USD/Unit)
Table 80. North America Sustained Release Injectables Sales by Country (2016-2021e) & (K Units)
Table 81. North America Sustained Release Injectables Sales by Country (2021-2026) & (K Units)
Table 82. North America Sustained Release Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Sustained Release Injectables Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 85. North America Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 86. North America Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 87. North America Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 88. Europe Sustained Release Injectables Sales by Country (2016-2021e) & (K Units)
Table 89. Europe Sustained Release Injectables Sales by Country (2021-2026) & (K Units)
Table 90. Europe Sustained Release Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Sustained Release Injectables Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 93. Europe Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 94. Europe Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 95. Europe Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 96. Asia-Pacific Sustained Release Injectables Sales by Region (2016-2021e) & (K Units)
Table 97. Asia-Pacific Sustained Release Injectables Sales by Region (2021-2026) & (K Units)
Table 98. Asia-Pacific Sustained Release Injectables Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Sustained Release Injectables Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 101. Asia-Pacific Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 102. Asia-Pacific Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 103. Asia-Pacific Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 104. South America Sustained Release Injectables Sales by Country (2016-2021e) & (K Units)
Table 105. South America Sustained Release Injectables Sales by Country (2021-2026) & (K Units)
Table 106. South America Sustained Release Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Sustained Release Injectables Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 109. South America Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 110. South America Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 111. South America Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 112. Middle East & Africa Sustained Release Injectables Sales by Country (2016-2021e) & (K Units)
Table 113. Middle East & Africa Sustained Release Injectables Sales by Country (2021-2026) & (K Units)
Table 114. Middle East & Africa Sustained Release Injectables Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Sustained Release Injectables Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Sustained Release Injectables Sales by Type (2016-2021e) & (K Units)
Table 117. Middle East & Africa Sustained Release Injectables Sales by Type (2021-2026) & (K Units)
Table 118. Middle East & Africa Sustained Release Injectables Sales by Application (2016-2021e) & (K Units)
Table 119. Middle East & Africa Sustained Release Injectables Sales by Application (2021-2026) & (K Units)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Sustained Release Injectables Typical Distributors
Table 123. Sustained Release Injectables Typical Customers
List of Figures
Figure 1. Sustained Release Injectables Picture
Figure 2. Global Sustained Release Injectables Sales Market Share by Type in 2020
Figure 3. Naltrexone
Figure 4. Exenatide
Figure 5. Estradiol
Figure 6. Other
Figure 7. Global Sustained Release Injectables Sales Market Share by Application in 2020
Figure 8. Diabetes
Figure 9. Leukemia
Figure 10. Acromegaly
Figure 11. Other
Figure 12. Global Sustained Release Injectables Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Sustained Release Injectables Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Sustained Release Injectables Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Sustained Release Injectables Sales (2016-2026) & (K Units)
Figure 34. Global Sustained Release Injectables Production Capacity (2016-2026) & (K Units)
Figure 35. Global Sustained Release Injectables Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Sustained Release Injectables Market Drivers
Figure 37. Sustained Release Injectables Market Restraints
Figure 38. Sustained Release Injectables Market Trends
Figure 39. Global Sustained Release Injectables Sales Market Share by Manufacturer in 2020
Figure 40. Global Sustained Release Injectables Revenue Market Share by Manufacturer in 2020
Figure 41. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Sustained Release Injectables Sales Market Share by Region (2016-2026)
Figure 45. Global Sustained Release Injectables Revenue Market Share by Region (2016-2026)
Figure 46. North America Sustained Release Injectables Revenue (2016-2026) & (USD Million)
Figure 47. Europe Sustained Release Injectables Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Sustained Release Injectables Revenue (2016-2026) & (USD Million)
Figure 49. South America Sustained Release Injectables Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Sustained Release Injectables Revenue (2016-2026) & (USD Million)
Figure 51. Global Sustained Release Injectables Sales Market Share by Type (2016-2026)
Figure 52. Global Sustained Release Injectables Revenue Market Share by Type (2016-2026)
Figure 53. Global Sustained Release Injectables Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 55. Global Sustained Release Injectables Revenue Market Share by Application (2016-2026)
Figure 56. Global Sustained Release Injectables Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Sustained Release Injectables Sales Market Share by Country (2016-2026)
Figure 58. North America Sustained Release Injectables Revenue Market Share by Country (2016-2026)
Figure 59. North America Sustained Release Injectables Sales Market Share by Type (2016-2026)
Figure 60. North America Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 61. Europe Sustained Release Injectables Sales Market Share by Country (2016-2026)
Figure 62. Europe Sustained Release Injectables Revenue Market Share by Country (2016-2026)
Figure 63. Europe Sustained Release Injectables Sales Market Share by Type (2016-2026)
Figure 64. Europe Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Sustained Release Injectables Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Sustained Release Injectables Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Sustained Release Injectables Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 69. South America Sustained Release Injectables Sales Market Share by Country (2016-2026)
Figure 70. South America Sustained Release Injectables Revenue Market Share by Country (2016-2026)
Figure 71. South America Sustained Release Injectables Sales Market Share by Type (2016-2026)
Figure 72. South America Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Sustained Release Injectables Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Sustained Release Injectables Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Sustained Release Injectables Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Sustained Release Injectables Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の徐放性賦形剤市場 2021：企業別、地域別、種類・用途別 The Sustained Release Excipients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 徐放性賦形剤の世界市場2018-2025 The sustained release excipients are one of the type of excipients that are added to the drug along with active pharmaceutical ingredients of medication. Sustained release excipients are pharmacologically non-active ingredients of the drug formulation.The Sustained Release Excipients market was valu…
- 世界の硝子体内（IVT）注射剤市場 2021：企業別、地域別、種類・用途別 The Intravitreal (IVT) Injectables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 顔面注射剤の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore…
- 世界の鋳造＆剥離紙市場 2021：企業別、地域別、種類・用途別 The Casting & Release Paper market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…